| Pharmaceutical Information |
| Drug Name |
Bromhexine |
| Drug ID |
BADD_D00302 |
| Description |
Bromhexine is mucolytic agent used for a variety of respiratory conditions associated with increased mucus secretion. It is derived from the Adhatoda vasica plant and aids in the clearance of excess mucus, improving breathing and reducing cough. It was introduced into the market in 1963, and is widely available as an over-the-counter drug in many countries.[A233240] Recently, bromhexine and its metabolite [ambroxol] have garnered interest for the potential prevention and treatment of COVID-19 due to their interactions with cell receptors in the lungs.[A233345,A233370] |
| Indications and Usage |
|
| Marketing Status |
Not Available |
| ATC Code |
R05CB02 |
| DrugBank ID |
DB09019
|
| KEGG ID |
D07542
|
| MeSH ID |
D001964
|
| PubChem ID |
2442
|
| TTD Drug ID |
D07UWJ
|
| NDC Product Code |
Not Available |
| Synonyms |
Bromhexine | Aparsonin | Bromhexin BC | BC, Bromhexin | Bromhexin Berlin-Chemie | Bromhexin Berlin Chemie | Bromhexin BerlinChemie | Bromhexine Hydrochloride | Hydrochloride, Bromhexine | Bromhexine Monohydrochloride | Monohydrochloride, Bromhexine | Brotussol | bromhexin von ct | ct, bromhexin von | von ct, bromhexin | Darolan | Dur-Elix | Dur Elix | DurElix | Famel Bromhexine | Bromhexine, Famel | Flegamin | Flubron | Hustentabs-ratiopharm | Hustentabs ratiopharm | Hustentabsratiopharm | Bromhexin-ratiopharm | Bromhexin ratiopharm | Bromhexinratiopharm | Mucohexine | NA-274 | NA 274 | NA274 | Tesacof | Bisolvon | Quentan | Bromhexin |
|
| Chemical Information |
| Molecular Formula |
C14H20Br2N2 |
| CAS Registry Number |
3572-43-8 |
| SMILES |
CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
